|
|
Article: Research from University of London, Imperial College yields new data on stem cell research.
- Article from:
- Biotech Week
- Article date:
- August 26, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Safe and prolonged drug delivery to the retina is a key obstacle to overcome in the development of new medicines aimed at treating progressive retinal disease. We took advantage of the ability of embryonic stem cells to survive long-term in foreign tissue and used these cells to deliver neuroprotectant molecules to the retina of the rhodopsin TgN S334ter-4 rat model of retinitis pigmentosa (RP)," scientists in London, the United Kingdom report (see also Stem Cell Research).
"Mouse embryonic stem (mES) cells, derived from the pluripotent embryonic stem cell line E14TG2a, were genetically engineered to oversecrete the glial cell-derived neurotrophic factor ...
Related newspaper, magazine, and journal articles:
|
|
Article: Research from Imperial College London, Department ...
Stem Cell Week;
September 21, 2009 ;
700+ words
... ... Nteliopoulos and colleagues, Imperial College London, Department of Haematology (see also Stem Cell Research). The researchers ... of Haematology, Imperial College London, London, UK ... Progenitor Cell, Stem Cell Research. This article ...
|
|